{"pmid":32275073,"title":"Response to Ribeiro da Silva et al.,\"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","text":["Response to Ribeiro da Silva et al.,\"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","We are writing regarding the Letter entitled \"Role of non-structural Proteins in the Pathogenesis of SARSCoV-2\" from Ribeiro da Silva et al., published in Journal of Medical Virology(1) . We welcome the discussion on published article, which could improve the science and clarify any controversial issues. This article is protected by copyright. All rights reserved.","J Med Virol","Ciccozzi, Massimo","Benvenuto, Domenico","Giovanetti, Marta","Bianchi, Martina","Pascarella, Stefano","Angeletti, Silvia","32275073"],"abstract":["We are writing regarding the Letter entitled \"Role of non-structural Proteins in the Pathogenesis of SARSCoV-2\" from Ribeiro da Silva et al., published in Journal of Medical Virology(1) . We welcome the discussion on published article, which could improve the science and clarify any controversial issues. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ciccozzi, Massimo","Benvenuto, Domenico","Giovanetti, Marta","Bianchi, Martina","Pascarella, Stefano","Angeletti, Silvia"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275073","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25863","source":"PubMed","weight":0,"_version_":1663712077968048129,"score":7.9164424,"similar":[{"pmid":32270884,"title":"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","text":["Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved.","J Med Virol","da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar","32270884"],"abstract":["We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270884","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25858","source":"PubMed","locations":["China","Wuhan","Sarbecovirus","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663620083000279040,"score":96.83738},{"pmid":32249944,"title":"About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis.","text":["About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis.","In the 5th February 2020 issue of Journal of Medical Virology a paper was published by Giovannetti et al., entitled \"The first two cases of 2019-nCoV in Italy: where they come from?\"(1) . In this paper a phylogenetic and evolutionary analysis was applied to the virus identified in the first two subjects diagnosed in Italy with 2019-nCoV infection, recently renamed SARS-CoV-2(2) , two Chinese spouses arrived in Italy for tourism. The diagnosis was performed by the virology team under direction of Maria R. Capobianchi, at the National Institute of Infectious Diseases (INMI) in Rome, Italy, where the patients are currently hospitalized. This article is protected by copyright. All rights reserved.","J Med Virol","Carletti, Fabrizio","Lalle, Eleonora","Messina, Francesco","Ippolito, Giuseppe","Capobianchi, Maria R","32249944"],"abstract":["In the 5th February 2020 issue of Journal of Medical Virology a paper was published by Giovannetti et al., entitled \"The first two cases of 2019-nCoV in Italy: where they come from?\"(1) . In this paper a phylogenetic and evolutionary analysis was applied to the virus identified in the first two subjects diagnosed in Italy with 2019-nCoV infection, recently renamed SARS-CoV-2(2) , two Chinese spouses arrived in Italy for tourism. The diagnosis was performed by the virology team under direction of Maria R. Capobianchi, at the National Institute of Infectious Diseases (INMI) in Rome, Italy, where the patients are currently hospitalized. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Carletti, Fabrizio","Lalle, Eleonora","Messina, Francesco","Ippolito, Giuseppe","Capobianchi, Maria R"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249944","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25833","keywords":["Coronavirus < Virus classification","Disease control","Statistical inference < Biostatistics & Bioinformatics"],"source":"PubMed","locations":["Italy","Chinese","Rome"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Mechanism"],"weight":1,"_version_":1663352136226832386,"score":76.78543},{"pmid":32239514,"title":"Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.","text":["Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.","We have read the article by Zhang et al. published in the recent issue of the Journal of Medical Virology(1) . Zhang and his colleagues have made a cross-sectional survey of currently registered clinical trials concerning 2019-nCoV, including the published literature. As such, they have given a preliminary assessment on the prospects of therapy for 2019-nCoV. This article is protected by copyright. All rights reserved.","J Med Virol","Yu, Yang","Shi, Qianling","Chen, Hao","32239514"],"abstract":["We have read the article by Zhang et al. published in the recent issue of the Journal of Medical Virology(1) . Zhang and his colleagues have made a cross-sectional survey of currently registered clinical trials concerning 2019-nCoV, including the published literature. As such, they have given a preliminary assessment on the prospects of therapy for 2019-nCoV. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yu, Yang","Shi, Qianling","Chen, Hao"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239514","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25806","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352135635435520,"score":66.79419},{"pmid":32246783,"title":"Response to Commentary on: \"The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients\".","text":["Response to Commentary on: \"The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients\".","In a recent review, we have suggested a neuroinvasive potential of SARS-CoV-2 and its possible role in the causation of acute respiratory failure of COVID-19 patients (J Med Viol doi: 10.1002/jmv.25728), based upon the clinical and experimental data available on the past SARS-CoV-1 and the recent SARS-CoV-2 pandemic. In this article, we provide new evidences recently reported regarding the neurotropic potential of SARS-CoV-2 and respond to several comments on our previously published article. In addition, we also discuss the peculiar manifestations of respiratory failure in COVID-19 patients and the possible involvement of nervous system. This article is protected by copyright. All rights reserved.","J Med Virol","Li, Yanchao","Bai, Wan-Zhu","Hashikawa, Tsutomu","32246783"],"abstract":["In a recent review, we have suggested a neuroinvasive potential of SARS-CoV-2 and its possible role in the causation of acute respiratory failure of COVID-19 patients (J Med Viol doi: 10.1002/jmv.25728), based upon the clinical and experimental data available on the past SARS-CoV-1 and the recent SARS-CoV-2 pandemic. In this article, we provide new evidences recently reported regarding the neurotropic potential of SARS-CoV-2 and respond to several comments on our previously published article. In addition, we also discuss the peculiar manifestations of respiratory failure in COVID-19 patients and the possible involvement of nervous system. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Yanchao","Bai, Wan-Zhu","Hashikawa, Tsutomu"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246783","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25824","keywords":["cell susceptibility","coronavirus","dissemination","nervous system"],"source":"PubMed","weight":0,"_version_":1663352135828373504,"score":60.06575},{"pmid":32265180,"title":"Genotype and phenotype of COVID-19: Their roles in pathogenesis.","text":["Genotype and phenotype of COVID-19: Their roles in pathogenesis.","COVID-19 is a novel coronavirus with an outbreak of unusual viral pneumonia in Wuhan, China, and then pandemic. Based on its phylogenetic relationships and genomic structures the COVID-19 belongs to genera Betacoronavirus. Human Betacoronaviruses (SARS-CoV-2, SARS-CoV, and MERS-CoV) have many similarities, but also have differences in their genomic and phenotypic structure that can influence their pathogenesis. COVID-19 is containing single-stranded (positive-sense) RNA associated with a nucleoprotein within a capsid comprised of matrix protein. A typical CoV contains at least six ORFs in its genome. All the structural and accessory proteins are translated from the sgRNAs of CoVs. Four main structural proteins are encoded by ORFs 10, 11 on the one-third of the genome near the 3'-terminus. The genetic and phenotypic structure of COVID-19 in pathogenesis is important. This article highlights the most important of these features compared to other Betacoronaviruses.","J Microbiol Immunol Infect","Mousavizadeh, Leila","Ghasemi, Sorayya","32265180"],"abstract":["COVID-19 is a novel coronavirus with an outbreak of unusual viral pneumonia in Wuhan, China, and then pandemic. Based on its phylogenetic relationships and genomic structures the COVID-19 belongs to genera Betacoronavirus. Human Betacoronaviruses (SARS-CoV-2, SARS-CoV, and MERS-CoV) have many similarities, but also have differences in their genomic and phenotypic structure that can influence their pathogenesis. COVID-19 is containing single-stranded (positive-sense) RNA associated with a nucleoprotein within a capsid comprised of matrix protein. A typical CoV contains at least six ORFs in its genome. All the structural and accessory proteins are translated from the sgRNAs of CoVs. Four main structural proteins are encoded by ORFs 10, 11 on the one-third of the genome near the 3'-terminus. The genetic and phenotypic structure of COVID-19 in pathogenesis is important. This article highlights the most important of these features compared to other Betacoronaviruses."],"journal":"J Microbiol Immunol Infect","authors":["Mousavizadeh, Leila","Ghasemi, Sorayya"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265180","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jmii.2020.03.022","keywords":["COVID-19","Genotype","Pathogenesis","Phenotype"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663609715706298368,"score":50.240288}]}